CEO Pascoe addresses ‘Silenor’ launch, w/ Procter and Gamble. Silenor is the first and only prescription product approved for the treatment of sleep maintenance insomnia that is not a controlled substance, with high tolerability, making Somaxon (SOMX), the manufacturer, an excellent investment opportunity (up over 300% in one year).
For information on Silenor and Insomnia, visit:
http://silenor.com/
http://www.facebook.com/home.php?#!/pages/Silenor/154427291248827
http://www.webmd.com/search/search_results/default.aspx?query=silenor&sourceType=undefined
Investors:
http://somaxon.com/
http://investors.somaxon.com/secfiling.cfm?filingID=950123-10-87531 (includes the slide presentation given by CEO Pascoe at the most recent UBS Global Life Sciences Conference in NYC, Exhibit 99.2)
http://cc.talkpoint.com/ubsx001/092110a_lv/?entity=122_W2DUHYS (audio of the above presentation)
Duration : 0:4:25
@fastmountscom
…
@fastmountscom
thanks for the info fastmounts
please keep us informed here
there have been, to date, several reports, all positive, of Silenor’s advantages over any of the other sleep meds, incl Ambien … but it’s early in the game since the product was launched just this Monday, the 20th
you can see some of the reports on the Somaxon Yahoo Finance message board … good luck
Was prescribed …
Was prescribed last week and was looking for info on it here. Not having bone chilling nightmares as before, was worth taking a chance.I wish they gave me this instead last year. Anyone else notice a difference?
At 10% Market Share …
At 10% Market Share .. Somaxon will achieve Annual Sales of $500M ++
Buy the Stock NOW! Before it goes to $30 !!
)
Key Statistics
Proctor & Gamble …
Proctor & Gamble Launch Next Generation Sleep Medication.. SOMX **
CEO on FOX News explains ..
Non addictive – No side effects for 7 Hours of Sleep
Introductory Pricing – Ask your Doctor Today!